drugset / Trial / NCT06372496
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this study is to assess and compare the effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma
Timeline
- Start
- 2024-04-16
- Primary completion
- 2025-07-28
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | — | — |
| Subject | Umeclidinium | Other / unclassified | — | — |
| Subject | Vilanterol | Other / unclassified | — | — |